Ming Yang Selected Research

Respiratory Hypersensitivity

1/2023	Inhibition of γ-glutamyl transferase suppresses airway hyperresponsiveness and airway inflammation in a mouse model of steroid resistant asthma exacerbation.
12/2021	Single-cell transcriptomic analysis reveals the immune landscape of lung in steroid-resistant asthma exacerbation.
11/2021	IL-17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus.
1/2020	Lipopolysaccharide induces steroid-resistant exacerbations in a mouse model of allergic airway disease collectively through IL-13 and pulmonary macrophage activation.
1/2018	ITGB4 is essential for containing HDM-induced airway inflammation and airway hyperresponsiveness.
1/2018	Identification of IFN-γ and IL-27 as Critical Regulators of Respiratory Syncytial Virus-Induced Exacerbation of Allergic Airways Disease in a Mouse Model.
1/2017	Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.
1/2016	Bromodomain and Extra Terminal (BET) Inhibitor Suppresses Macrophage-Driven Steroid-Resistant Exacerbations of Airway Hyper-Responsiveness and Inflammation.
8/2015	MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.
1/2013	Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Yang Research Topics

Disease

308	Neoplasms (Cancer) 04/2024 - 07/2003
109	Inflammation (Inflammations) 02/2024 - 04/2002
65	Infections 02/2024 - 09/2003
45	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2007
45	Asthma (Bronchial Asthma) 01/2023 - 04/2002
42	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2007
36	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2010
28	Carcinogenesis 12/2023 - 06/2007
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 10/2009
26	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2005
26	Fibrosis (Cirrhosis) 12/2023 - 10/2010
26	Lung Neoplasms (Lung Cancer) 11/2023 - 05/2007
24	Wounds and Injuries (Trauma) 04/2022 - 06/2004
22	Hypoxia (Hypoxemia) 02/2024 - 07/2009
22	Stomach Neoplasms (Stomach Cancer) 02/2024 - 07/2008
22	COVID-19 12/2023 - 01/2020
21	Stroke (Strokes) 02/2024 - 01/2010
21	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 01/2016
20	Obesity 03/2024 - 01/2013
18	Hemorrhage 04/2024 - 11/2011
18	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 07/2003
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 06/2010
17	Glioma (Gliomas) 04/2023 - 02/2007
16	Myocardial Infarction 01/2024 - 07/2007
16	Liver Neoplasms (Liver Cancer) 12/2023 - 01/2015
16	Sarcopenia 11/2023 - 04/2017
16	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 10/2009
15	Adenocarcinoma of Lung 01/2023 - 03/2013
14	Insulin Resistance 03/2024 - 06/2012
14	Type 2 Diabetes Mellitus (MODY) 03/2024 - 10/2007
14	Body Weight (Weight, Body) 02/2024 - 04/2003
14	Ischemic Stroke 02/2024 - 01/2013
14	Hypertension (High Blood Pressure) 12/2023 - 04/2011
14	Carcinoma (Carcinomatosis) 08/2023 - 04/2007
14	Non-alcoholic Fatty Liver Disease 06/2023 - 10/2020
14	Leukemia 03/2023 - 06/2008
13	Pain (Aches) 02/2024 - 09/2003
13	Ulcerative Colitis 01/2024 - 05/2004
13	Cachexia 01/2024 - 01/2021
13	Thrombosis (Thrombus) 07/2023 - 04/2002
13	Disease Progression 05/2023 - 01/2016
13	Respiratory Hypersensitivity 01/2023 - 04/2009
13	Pneumonia (Pneumonitis) 01/2023 - 02/2010
13	Heart Failure 01/2022 - 04/2003
12	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 05/2015
12	Fever (Fevers) 05/2024 - 05/2007
12	Melanoma (Melanoma, Malignant) 01/2022 - 08/2011
11	Atherosclerosis 12/2023 - 02/2013
11	Lymphoma (Lymphomas) 10/2023 - 12/2003
11	Hyperlipidemias (Hyperlipidemia) 01/2023 - 02/2013
10	Liver Diseases (Liver Disease) 05/2024 - 01/2016
10	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 03/2009

Drug/Important Bio-Agent (IBA)

106	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
100	Biomarkers (Surrogate Marker)IBA 05/2024 - 05/2008
50	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2007
37	CytokinesIBA 02/2024 - 06/2002
31	Long Noncoding RNAIBA 01/2024 - 09/2014
30	Indicators and Reagents (Reagents)IBA 01/2024 - 04/2007
30	EnzymesIBA 12/2022 - 09/2009
29	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2011
28	Messenger RNA (mRNA)IBA 12/2023 - 06/2003
26	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 10/2012
25	Therapeutic UsesIBA 05/2024 - 01/2006
22	LipidsIBA 12/2023 - 01/2013
19	Volatile Oils (Essential Oils)IBA 05/2024 - 01/2019
18	AlbuminsIBA 01/2024 - 07/2008
17	Interleukin-6 (Interleukin 6)IBA 02/2024 - 10/2009
17	AntioxidantsIBA 02/2024 - 01/2013
17	C-Reactive ProteinIBA 01/2024 - 01/2006
17	CreatinineIBA 11/2023 - 07/2008
17	AntibodiesIBA 04/2023 - 12/2003
17	SteroidsIBA 01/2023 - 04/2009
16	ErbB Receptors (EGF Receptor)IBA 01/2024 - 02/2007
16	Monoclonal AntibodiesIBA 11/2023 - 03/2004
14	CholesterolIBA 02/2024 - 12/2012
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2006
14	Peptides (Polypeptides)IBA 12/2023 - 04/2009
14	Insulin (Novolin)FDA Link 01/2023 - 10/2003
13	Antiviral Agents (Antivirals)IBA 09/2023 - 12/2005
13	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2003
12	LipopolysaccharidesIBA 05/2024 - 02/2014
12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 01/2008
12	Transcription Factors (Transcription Factor)IBA 01/2024 - 12/2013
12	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 10/2013
12	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2005
11	Interleukin-10 (Interleukin 10)IBA 02/2024 - 10/2009
11	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 06/2004
11	AntigensIBA 10/2023 - 11/2006
11	CollagenIBA 06/2023 - 04/2002
11	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2016
11	VaccinesIBA 01/2023 - 05/2007
11	IntegrinsIBA 09/2022 - 10/2010
10	Phosphotransferases (Kinase)IBA 02/2024 - 06/2008

Therapy/Procedure

200	Therapeutics 04/2024 - 09/2002
46	Drug Therapy (Chemotherapy) 04/2024 - 08/2007
27	Radiotherapy 11/2023 - 04/2010
22	Immunotherapy 12/2023 - 02/2008
22	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 05/2010
14	Aftercare (After-Treatment) 10/2022 - 10/2009
13	Stents 01/2022 - 03/2009